Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

Data Compilation
#PharmaFlow

Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

Stock Recap
#PipelineProspector

Arpizol

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

152 API Suppliers, 56 USDMF, 28 CEP/COS, 8 JDMF, 25 EU WC, 19 KDMF, 43 NDC API, 76 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

99 Drugs in Development

99 Drugs in Development

INTERMEDIATES

50 Intermediate Suppliers

50 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1180 FDF Dossiers, 191 FDA Orange Book, 659 Europe, 86 Canada, 33 Australia, 49 South Africa, 162 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 300MG/VIAL, FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 400MG/VIAL, TABLET;ORAL - 10MG, TABLET;ORAL - 15MG, TABLET;ORAL - 20MG, TABLET;ORAL - 2MG, TABLET;ORAL - 30MG, TABLET;ORAL - 5MG, TABLET;ORAL - 10MG, TABLET;ORAL - 15MG, TABLET;ORAL - 20MG, TABLET;ORAL - 2MG, TABLET;ORAL - 30MG, TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 Evonik, 5 Rochem International Inc, 18 SPI Pharma, 10 DKSH, 1 Pharm-RX Chemical, 5 Boai NKY Pharmaceuticals Ltd, 7 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 1 Capital Farma, 3 Kirsch Pharma, 1 ACG Worldwide, 4 Actylis, 1 Alcedo Pharmachem, 9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 15 BASF, 1 Bioplus Life Sciences, 1 CD Formulation, 11 Corel Pharma Chem, 5 DFE Pharma, 1 Finar, 9 Gangwal Chemicals, 4 Ideal Cures, 4 Ingredion Pharma Solutions, 20 Kerry, 2 Keval Exports, 4 Kima Chemical, 6 Lonza Capsugel, 16 Microlex e.U, 2 Nitika Pharmaceutical Specialities, 3 Novo Excipients, 3 Pharmatrans-Sanaq, 8 Pluviaendo, 3 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 16 Roquette, 7 Seppic, 7 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 4 Silverline Chemicals, 3 The Dow Chemical Company, 1 Ulanqab Kema New Material, 1 Valens Pharmachem, 4 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 40 Coating Systems & Additives, 35 Disintegrants & Superdisintegrants, 35 Direct Compression, 29 Granulation, 28 Taste Masking, 25 Thickeners and Stabilizers, 22 Chewable & Orodispersible Aids, 21 Controlled & Modified Release, 17 Parenteral, 17 Solubilizers, 14 Lubricants & Glidants, 12 Film Formers & Plasticizers, 12 Co-Processed Excipients, 8 Topical, 6 Emulsifying Agents, 5 Empty Capsules, 5 Rheology Modifiers, 4 Vegetarian Capsules, 4 API Stability Enhancers, 2 Coloring Agents, 1 Surfactant & Foaming Agents, 1 Dry Powder Inhalation

DIGITAL CONTENT

1 Data Compilation #PharmaFlow, 114 News #PharmaBuzz

GLOBAL SALES INFORMATION

33 US Medicaid Prescriptions, 206 Regulatory FDF Prices, 33 Annual Reports

MARKET PLACE

22 APIs, 8 FDF Dossiers

PATENTS & EXCLUSIVITIES

284 US Patents, 98 Health Canada Patents

REF. STANDARDS & IMPURITIES

2 EDQM, 19 USP, 21 Others

ANALYTICAL

3 BioAnalytical Methods, 1 Analytical Methods

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Certificate Holder	Certificate No.	Substance	Issue Date	Status	Type	End Date	Substance No.
29/11/2025	Cohance Lifesciences	India	COHANCE LIFESCIENCES LIMITED Mumbai IN	CEP 2016-021 - Rev 02	Aripiprazole	2024-07-09	Valid	Chemical		2617
29/11/2025	Egis Pharmaceuticals PLC	Hungary	EGIS Pharmaceuticals PLC Budapest HU	R1-CEP 2014-252 - Rev 02	Aripiprazole	2022-07-21	Valid	Chemical		2617

Arpizol

Arpizol

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

152 API Suppliers

56 USDMF

28 CEP/COS

8 JDMF

25 EU WC

19 KDMF

43 NDC API

76 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

99 Drugs in Development

INTERMEDIATES

50 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

1180 FDF Dossiers

191 FDA Orange Book

659 Europe

86 Canada

33 Australia

49 South Africa

162 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 300MG/VIAL

FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR - 400MG/VIAL

TABLET;ORAL - 10MG

TABLET;ORAL - 15MG

TABLET;ORAL - 20MG

TABLET;ORAL - 2MG

TABLET;ORAL - 30MG

TABLET;ORAL - 5MG

TABLET;ORAL - 10MG

TABLET;ORAL - 15MG

TABLET;ORAL - 20MG

TABLET;ORAL - 2MG

TABLET;ORAL - 30MG

TABLET;ORAL - 5MG

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 Evonik

5 Rochem International Inc

18 SPI Pharma

10 DKSH

1 Pharm-RX Chemical

5 Boai NKY Pharmaceuticals Ltd

7 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

2 Pfanstiehl

1 Capital Farma

3 Kirsch Pharma

1 ACG Worldwide

4 Actylis

1 Alcedo Pharmachem

9 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

15 BASF

1 Bioplus Life Sciences

1 CD Formulation

11 Corel Pharma Chem

5 DFE Pharma

1 Finar

9 Gangwal Chemicals

4 Ideal Cures

4 Ingredion Pharma Solutions

20 Kerry

2 Keval Exports

4 Kima Chemical

6 Lonza Capsugel

16 Microlex e.U

2 Nitika Pharmaceutical Specialities

3 Novo Excipients

3 Pharmatrans-Sanaq

8 Pluviaendo

3 Prachin Chemical